Amsterdam
Netherlands
7
2023-10-19
4
2024-04-09
These are the the leading inventors for applications assigned to AGENDIA N.V.:
AGENDIA N.V. based in Amsterdam, NL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
TREATMENT OF HER2 NEGATIVE, MAMMAPRINT HIGH RISK 2 BREAST CANCER
#2 | 2022-05-12 ✅ Patent 11,954,859 granted on 2024-04-09Methods of assessing diseases using image classifiers
#3 | 2017-10-12Method and Means for Typing a Sample Comprising Cancer Cells Based on Oncogenic Signal Transduction Pathways
#4 | 2016-04-28 ✅ Patent 10,072,301 granted on 2018-09-11Means and methods for molecular classification of breast cancer
#5 | 2013-11-14Methods and Means for Typing a Sample Comprising Cancer Cells Based on Oncogenic Signal Transduction Pathways
#6 | 2013-11-07 ✅ Patent 10,036,070 granted on 2018-07-31Methods and means for molecular classification of colorectal cancers
#7 | 2013-07-11 ✅ Patent 9,175,351 granted on 2015-11-03Means and methods for molecular classification of breast cancer
Also check out Agendia N.V.'s (Amsterdam, Netherlands) applicant profile with 3 patent applications submitted.
45271 ⎘